Search - tctmd.com

Displaying 301 - 320 of 358

Sort: Relevancy | Date

News Conference News

ZES and SES Equally Effective in Long Lesion Treatment

November 08, 2011

News Conference News

SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology

November 08, 2011

News Conference News

Safety, Efficacy Reported with FIREHAWK SES

November 08, 2011

News Conference News

Preclinical Results Promising for Combo Stent

November 08, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

News Conference News

EES Compared Favorably with SES In Two Pivotal Trials

November 08, 2011

News Conference News

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

November 08, 2011

News Conference News

ZES, EES Noninferior to PES

November 07, 2011

News Industry News

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

November 07, 2011

News Conference News

EES Associated with Reduced MACE Compared with SES

November 07, 2011

News Conference News

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

November 06, 2011

News Conference News

DES Noninferior for Survival Compared with BMS in STEMI

November 06, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 03, 2011

News Industry News

Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent

November 01, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

September 19, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

Advertisement

ZES and SES Equally Effective in Long Lesion Treatment

SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology

Safety, Efficacy Reported with FIREHAWK SES

Preclinical Results Promising for Combo Stent

Low Event Rates with EES Sustained at 2 Years

EES Compared Favorably with SES In Two Pivotal Trials

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

ZES, EES Noninferior to PES

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

EES Associated with Reduced MACE Compared with SES

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

DES Noninferior for Survival Compared with BMS in STEMI

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Abbott to Present New Data for Key Vascular Products at TCT 2011

Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content